These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 38026439)

  • 1. Bioresponsive and immunotherapeutic nanomaterials to remodel tumor microenvironment for enhanced immune checkpoint blockade.
    Fang T; Cao X; Wang L; Chen M; Deng Y; Chen G
    Bioact Mater; 2024 Feb; 32():530-542. PubMed ID: 38026439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functionalized biomimetic nanoparticles combining programmed death-1/programmed death-ligand 1 blockade with photothermal ablation for enhanced colorectal cancer immunotherapy.
    Xiao Y; Zhu T; Zeng Q; Tan Q; Jiang G; Huang X
    Acta Biomater; 2023 Feb; 157():451-466. PubMed ID: 36442821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T cell-mediated targeted delivery of tadalafil regulates immunosuppression and polyamine metabolism to overcome immune checkpoint blockade resistance in hepatocellular carcinoma.
    Wang X; Zhang Q; Zhou J; Xiao Z; Liu J; Deng S; Hong X; Huang W; Cai M; Guo Y; Huang J; Wang Y; Lin L; Zhu K
    J Immunother Cancer; 2023 Feb; 11(2):. PubMed ID: 36813307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced Osteosarcoma Immunotherapy via CaCO
    Gao Y; Wang Z; Jin X; Wang X; Tao Y; Huang S; Wang Y; Hua Y; Guo X; Xu J; Cai Z
    Adv Healthc Mater; 2024 Sep; 13(23):e2400538. PubMed ID: 38759954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment.
    Yang M; Li J; Gu P; Fan X
    Bioact Mater; 2021 Jul; 6(7):1973-1987. PubMed ID: 33426371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Dual-Bioresponsive Drug-Delivery Depot for Combination of Epigenetic Modulation and Immune Checkpoint Blockade.
    Ruan H; Hu Q; Wen D; Chen Q; Chen G; Lu Y; Wang J; Cheng H; Lu W; Gu Z
    Adv Mater; 2019 Apr; 31(17):e1806957. PubMed ID: 30856290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Janus Silica Nanoparticle-Based Tumor Microenvironment Modulator for Restoring Tumor Sensitivity to Programmed Cell Death Ligand 1 Immune Checkpoint Blockade Therapy.
    Lin X; Li F; Guan J; Wang X; Yao C; Zeng Y; Liu X
    ACS Nano; 2023 Aug; 17(15):14494-14507. PubMed ID: 37485850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colorectal Tumor Microenvironment-Activated Bio-Decomposable and Metabolizable Cu
    Chang M; Hou Z; Jin D; Zhou J; Wang M; Wang M; Shu M; Ding B; Li C; Lin J
    Adv Mater; 2020 Oct; 32(43):e2004647. PubMed ID: 32945002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multifunctional Calcium-Manganese Nanomodulator Provides Antitumor Treatment and Improved Immunotherapy via Reprogramming of the Tumor Microenvironment.
    Luo G; Li X; Lin J; Ge G; Fang J; Song W; Xiao GG; Zhang B; Peng X; Duo Y; Tang BZ
    ACS Nano; 2023 Aug; 17(16):15449-15465. PubMed ID: 37530575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor Microenvironment-Activable Manganese-Boosted Catalytic Immunotherapy Combined with PD-1 Checkpoint Blockade.
    Zhao Z; Dong S; Liu Y; Wang J; Ba L; Zhang C; Cao X; Wu C; Yang P
    ACS Nano; 2022 Dec; 16(12):20400-20418. PubMed ID: 36441901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial Ca
    Zhu J; Jiao A; Li Q; Lv X; Wang X; Song X; Li B; Zhang Y; Dong X
    Acta Biomater; 2022 Jan; 137():252-261. PubMed ID: 34653696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multifunctional nanoparticles precisely reprogram the tumor microenvironment and potentiate antitumor immunotherapy after near-infrared-II light-mediated photothermal therapy.
    Ge Y; Zhang J; Jin K; Ye Z; Wang W; Zhou Z; Ye J
    Acta Biomater; 2023 Sep; 167():551-563. PubMed ID: 37302731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multifunctional nanodrug performs sonodynamic therapy and inhibits TGF-β to boost immune response against colorectal cancer and liver metastasis.
    Huang S; Ding D; Lan T; He G; Ren J; Liang R; Zhong H; Chen G; Lu X; Shuai X; Wei B
    Acta Biomater; 2023 Jul; 164():538-552. PubMed ID: 37037269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of ultrasound-based mechanical disruption of tumor with immune checkpoint blockade modifies tumor microenvironment and augments systemic antitumor immunity.
    Abe S; Nagata H; Crosby EJ; Inoue Y; Kaneko K; Liu CX; Yang X; Wang T; Acharya CR; Agarwal P; Snyder J; Gwin W; Morse MA; Zhong P; Lyerly HK; Osada T
    J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35039461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CaCO
    Zhu Y; Yang Z; Dong Z; Gong Y; Hao Y; Tian L; Yang X; Liu Z; Feng L
    Nanomicro Lett; 2020 Nov; 13(1):29. PubMed ID: 34138248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blocking LTB
    Yan J; Zhu J; Li X; Yang R; Xiao W; Huang C; Zheng C
    Phytomedicine; 2023 Oct; 119():154968. PubMed ID: 37531900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Augmenting Immunotherapy via Bioinspired MOF-Based ROS Homeostasis Disruptor with Nanozyme-Cascade Reaction.
    Wang R; Qiu M; Zhang L; Sui M; Xiao L; Yu Q; Ye C; Chen S; Zhou X
    Adv Mater; 2023 Dec; 35(49):e2306748. PubMed ID: 37689996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Hierarchical Structured Fiber Device Remodeling the Acidic Tumor Microenvironment for Enhanced Cancer Immunotherapy.
    Li Y; Yuan R; Luo Y; Guo X; Yang G; Li X; Zhou S
    Adv Mater; 2023 May; 35(21):e2300216. PubMed ID: 36912443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intratumoral immunotherapy using a TLR2/3 agonist, L-pampo, induces robust antitumor immune responses and enhances immune checkpoint blockade.
    Lee WS; Kim DS; Kim JH; Heo Y; Yang H; Go EJ; Kim JH; Lee SJ; Ahn BC; Yum JS; Chon HJ; Kim C
    J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35764365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor acidity-activatable macromolecule autophagy inhibitor and immune checkpoint blockade for robust treatment of prostate cancer.
    Wang Y; Lei H; Yan B; Zhang S; Xu B; Lin M; Shuai X; Huang J; Pang J
    Acta Biomater; 2023 Sep; 168():593-605. PubMed ID: 37474083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.